Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights.
作者： Jason S Starr , Mohamad Bassam Sonbol , Timothy J Hobday , Akash Sharma , Ayse Tuba Kendi
DOI: 10.2147/OTT.S202867
关键词: Retrospective cohort study 、 Patient population 、 Oncology 、 Neuroendocrine tumors 、 Randomized controlled trial 、 Pancreatic neuroendocrine tumor 、 Peptide receptor 、 Radionuclide therapy 、 Medicine 、 Internal medicine
摘要: Peptide receptor radionuclide therapy (PRRT) is a paradigm shifting approach to the treatment of neuroendocrine tumors. Although there are no prospective randomized trials directly studying PRRT in pancreatic tumors (panNETs), data suggest benefit this patient population. Collectively, data, consisting two and six retrospective studies, show median PFS ranging from 20 39 months OS 37 79 months. There ongoing (and upcoming) prospective, panNETs, which will provide further evidence support approach.
elsevier.com
sci-hub.se 参考文章(105)
Peter Bartenstein, Christoph Auernhammer, Alexander Haug, Julia Geisler, Marcus Hacker, Christoph Zech, Toxicity of sequential treatment with radioembolization and PRRT in hepatic metastasized neuroendocrine tumors The Journal of Nuclear Medicine. ,vol. 53, pp. 1189- 1189 ,(2012)
Phillip G. Claringbold, J. Harvey Turner, Pancreatic Neuroendocrine Tumor Control: Durable Objective Response to Combination 177Lu-Octreotate-Capecitabine-Temozolomide Radiopeptide Chemotherapy Neuroendocrinology. ,vol. 103, pp. 432- 439 ,(2016) , 10.1159/000434723
Christoph Rochlitz, Nicolas Marincek, Helmut R Maecke, Piotr Radojewski, Jan Müller-Brand, Matthias Briel, Philippe Brunner, Martin Alexander Walter, Rebecca A Dumont, Daniela Seiler, Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma American journal of nuclear medicine and molecular imaging. ,vol. 5, pp. 46- 55 ,(2015) , 10.7892/BORIS.67183
Julie Hallet, Calvin How Lim Law, Moises Cukier, Refik Saskin, Ning Liu, Simron Singh, Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomes Cancer. ,vol. 121, pp. 589- 597 ,(2015) , 10.1002/CNCR.29099
Annapaola Mariniello, Lisa Bodei, Carmine Tinelli, Silvia Melania Baio, Laura Gilardi, Marzia Colandrea, Stefano Papi, Giuseppe Valmadre, Nicola Fazio, Domenico Galetta, Giovanni Paganelli, Chiara Maria Grana, Long-term results of PRRT in advanced bronchopulmonary carcinoid European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 43, pp. 441- 452 ,(2016) , 10.1007/S00259-015-3190-7
H Ohnishi, T Mine, I Kojima, Inhibition by somatostatin of amylase secretion induced by calcium and cyclic AMP in rat pancreatic acini Biochemical Journal. ,vol. 304, pp. 531- 536 ,(1994) , 10.1042/BJ3040531
E. P. KRENNING, P. P. M. KOOIJ, W. H. BAKKER, W. A. P. BREEMAN, P. T. E. POSTEMA, D. J. KWEKKEBOOM, H. Y. OEI, M. JONG, T. J. VISSER, A. E. M. REIJS, S. W. J. LAMBERTS, Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history. Annals of the New York Academy of Sciences. ,vol. 733, pp. 496- 506 ,(1994) , 10.1111/J.1749-6632.1994.TB17300.X
Christodoulos P Pipinikas, Harpreet Dibra, Anna Karpathakis, Andrew Feber, Marco Novelli, Dahmane Oukrif, Guiseppe Fusai, Roberto Valente, Martyn Caplin, Tim Meyer, Andrew Teschendorff, Christopher Bell, Tiffany J Morris, Paolo Salomoni, Tu-Vinh Luong, Brian Davidson, Stephan Beck, Christina Thirlwell, Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours Endocrine-related Cancer. ,vol. 22, ,(2015) , 10.1530/ERC-15-0108
Lisa Bodei, Mark Kidd, Giovanni Paganelli, Chiara M. Grana, Ignat Drozdov, Marta Cremonesi, Christopher Lepensky, Dik J. Kwekkeboom, Richard P. Baum, Eric P. Krenning, Irvin M. Modlin, Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 42, pp. 5- 19 ,(2015) , 10.1007/S00259-014-2893-5
Maddalena Sansovini, Stefano Severi, Alice Ambrosetti, Manuela Monti, Oriana Nanni, Anna Sarnelli, Lisa Bodei, Lucia Garaboldi, Mirco Bartolomei, Giovanni Paganelli, Treatment with the radiolabelled somatostatin analog Lu-DOTATATE for advanced pancreatic neuroendocrine tumors. Neuroendocrinology. ,vol. 97, pp. 347- 354 ,(2013) , 10.1159/000348394